BackgroundCheck.run
Search For

Jonathan M Finn, 55164 Wessagussett Rd, North Weymouth, MA 02191

Jonathan Finn Phones & Addresses

164 Wessagussett Rd, North Weymouth, MA 02191    781-8036099    978-7646816   

Weymouth, MA   

Hingham, MA   

Boston, MA   

Braintree, MA   

Colorado Springs, CO   

Andover, MA   

Killeen, TX   

Fort Leavenworth, KS   

Summerville, OR   

620 Huntington Ave, Boston, MA 02115   

Work

Position: Service Occupations

Mentions for Jonathan M Finn

Jonathan Finn resumes & CV records

Resumes

Jonathan Finn Photo 37

Leader Of Jon Finn Group

Location:
Greater Boston Area
Industry:
Music
Jonathan Finn Photo 38

Senior Account Executive

Location:
North Weymouth, MA
Industry:
Insurance
Work:
Brown & Brown Insurance Oct 2012 - Dec 2015
Account Executive
Zurich North America Jan 2000 - Oct 2012
Account Executive
Gowrie Group Jan 2000 - Oct 2012
Senior Account Executive
Education:
Norwich University 1988 - 1992
Bachelors, History
Skills:
Commercial Insurance, Property and Casualty Insurance, Insurance, General Insurance, Umbrella Insurance, Casualty Insurance, Legal Liability, Liability, Underwriting
Jonathan Finn Photo 39

Jonathan Finn

Publications & IP owners

Us Patents

Modified Aav Capsid Proteins For Treatment Of Arthritic Disease

US Patent:
2022026, Aug 25, 2022
Filed:
Jul 15, 2020
Appl. No.:
17/627364
Inventors:
- London, GB
- Heidelberg, DE
Niels Broekstra - Nieuwkoop, NL
Jonathan Douglas Finn - Melrose MA, US
Dirk Grimm - Heidelberg, DE
Kathleen Börner - Schriesheim, DE
International Classification:
C12N 15/86
C07K 14/005
A61P 19/02
A61K 45/06
A61K 38/16
Abstract:
The invention relates to recombinant adeno-associated virus (rAAV) virions for gene therapy, wherein the rAAV virions comprise a novel capsid protein. In particular, the invention relates to the use of such virions in gene therapy for the treatment of an arthritic disease, such as for example rheumatoid arthritis, or symptoms thereof, preferably by intraarticular administration.

Extracellular Vesicles For Treating Neurological Disorders

US Patent:
2023011, Apr 13, 2023
Filed:
Mar 15, 2021
Appl. No.:
17/906177
Inventors:
- Cambridge MA, US
Tim SOOS - Boston MA, US
Nikki ROSS - Philadelphia PA, US
Christine MCCOY - Cambridge MA, US
Jonathan FINN - Melrose MA, US
Sriram SATHYANARAYANAN - Lexington MA, US
Shailendra PATEL - Boston MA, US
Ke XU - Belmont MA, US
Russell E. MCCONNELL - Cambridge MA, US
Kevin P. DOOLEY - Boston MA, US
Assignee:
Codiak BioSciences, Inc. - Cambridge MA
International Classification:
A61K 39/00
A61P 25/28
A61K 39/39
A61P 35/00
A61K 31/436
A61K 31/593
A61K 31/203
A61K 31/573
A61K 31/7088
A61K 47/69
A61K 47/64
A61H 23/00
A61H 23/02
Abstract:
The present disclosure relates to extracellular vesicles (EVs) that are capable of targeting a cell in the CNS of a subject. Also provided herein are methods for producing the EVs and methods for using the EVs to treat and/or prevent diseases or disorders of the CNS (e.g., neurological disorders).

Polynucleotides, Compositions, And Methods For Genome Editing

US Patent:
2020035, Nov 12, 2020
Filed:
Mar 24, 2020
Appl. No.:
16/828615
Inventors:
- Cambridge MA, US
Jonathan Douglas Finn - Melrose MA, US
Amy Madison Rhoden Smith - Durham NC, US
Seth C. Alexander - Medford MA, US
Assignee:
Intellia Therapeutics, Inc. - Cambridge MA
International Classification:
C12N 9/22
C12N 15/11
A61K 9/51
Abstract:
Compositions and methods for gene editing. In some embodiments, a polynucleotide encoding Cas9 is provided that can provide one or more of improved editing efficiency, reduced immunogenicity, or other benefits.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.